Sarcopenia clinical trials
27 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
- Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
- The Foods & Oil to Repair, Correct and Enhance Strength (FORCES) Study
- Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Health Promotion With Targeted Exercise Intervention for Decreasing Fall Risk and Inactivity in Aging Veterans With Obesity and Signs of Sarcopenia
- Strength Training and Resveratrol
- MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU Patients
- Adverse Outcomes and Mortality in Liver Transplant
- Mental Effort During Low Load Resistance Training in Older Adults
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
- Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery
- QOL and Sarcopenia in Patients With Ascites
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
- The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
- C-Protein in Fatigue and Aging
- Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses
- BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4
- Time Efficient Exercise to Reverse Sarcopenia and Improve Cardio-metabolic Health
- Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
- Sarcopenia in Chronic Kidney Disease (CKD) Patients
- Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors
- Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan Cohort
- Peanut Sip Feeding Protocol
- Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)
- Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Sarcopenia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.